All results
2 results for reduced craniospinal radiation therapy and chemotherapy treating younger patients
-
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mix
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia…
- Ages
- 1 Year - 25 Years
- Sexes
- All
-
Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adol
This phase III trial compares hematopoietic (stem) cell transplantation (HCT) using mismatched related donors (haploidentical [haplo]) versus matched unrelated…
- Ages
- 6 Months - 21 Years
- Sexes
- All